Sub-navigation Navigation links - Current: Sub-navigation - [ Investments ](/en/about-us/annual-reports/hus-year-2024/finances/hus-year-2024-investments) - [ Operating revenue and operating costs ](/en/about-us/annual-reports/hus-year-2024/finances/hus-year-2024-operating-revenue-and-operating-costs) - [ Productivity, service production and funding ](/en/about-us/annual-reports/hus-year-2024/finances/hus-year-2024-productivity-service-production-and) - [ Investments ](/en/about-us/annual-reports/hus-year-2024/finances/hus-year-2024-investments) - [ Operating revenue and operating costs ](/en/about-us/annual-reports/hus-year-2024/finances/hus-year-2024-operating-revenue-and-operating-costs) - [ Productivity, service production and funding ](/en/about-us/annual-reports/hus-year-2024/finances/hus-year-2024-productivity-service-production-and) # HUS year 2024: Operating revenue and operating costs ## Operating revenue Our operating revenue for 2024 came to EUR 3,056.8 million. Operating revenue fell short of the budget by 0.6%, or EUR 18.1 million. The budget framework for fixed member billing totaled EUR 2,206 million, and we invoiced members accordingly. Actual use of services covered by the budget framework in 2024 exceeded the framework by EUR 153.3 million. We were unable to bill the difference because of the fixed funding scheme. A key reason for the underperformance in operating revenues was the lower than expected revenues from diagnostic and out-of-framework specialized healthcare services. ## Operating costs Our operating costs totaled EUR 2,950 million. This exceeded the budget by 0.4%, or EUR 13 million. The overrun was due to the volume of service production, which was higher than budgeted. ## Personnel expenses The total number of person-years worked was 21,946. Personnel costs amounted to EUR 1,647.6 million, falling short of the budget by EUR 20.2 million, or 1.2%. Personnel costs increased by 2.7% from the previous year. ## Purchased services Purchases of services exceeded the budget by 2.5%, or EUR 15.3 million. The overrun was due to a higher level of service production than planned, particularly in the purchases of outpatient and inpatient care in the units of Musculoskeletal and Plastic Surgery and the Heart and Lung Center. ## Purchases of materials, supplies and pharmaceuticals The cost of materials, supplies and pharmaceuticals exceeded the budget by 5.7%, or EUR 29.6 million. The overrun was mainly due to pharmaceuticals and pharmacy supplies, which were purchased in an amount of EUR 17.5 million more than planned, and medical supplies, which were purchased in an amount of EUR 10.4 million more than planned. ## Other operating costs Other operating expenses were 8.6% or EUR 11.6 million below the budget, due to lower than planned rents for premises and equipment. ## Depreciation and reductions in value Depreciation and reductions in value exceeded the budget by 3.0%, or EUR 3.6 million. The overrun was due to fixed assets and depreciations according to plan being higher than expected. Updated: 04.04.2025 Print this page